| Distribution | Full List | Categories |
| by Country | by Vaccine |
| PEOPLE VACCINATED | LAST 7 DAYS | |||||
| countries over 1M population |
1st dose |
last dose |
1st dose |
last dose |
any dose |
|
| Netherlands |
144.2% 24,715,243 |
135.4% 23,205,935 |
0.0% | 0.0% |
0.2% 42k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| United Arab Emirates |
101.0% 9,991,089 |
99.0% 9,792,266 |
0.1% 6k |
|||
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Portugal |
95.4% 9,729,123 |
87.1% 8,884,776 |
0.0% | 0.0% |
0.8% 86k |
|
| Covaxin, Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Cuba |
94.3% 10,679,168 |
88.1% 9,973,753 |
0.0% | 0.0% |
1.9% 214k |
|
| Abdala, Soberana Plus, Soberana02 | ||||||
| Chile |
94.2% 18,002,453 |
92.0% 17,579,092 |
0.0% | 0.1% |
1.9% 365k |
|
| CanSino, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Qatar |
91.8% 2,646,349 |
91.8% 2,646,349 |
0.1% | 0.1% |
0.8% 22k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Argentina |
91.1% 41,158,600 |
83.1% 37,574,013 |
0.0% | 0.0% |
0.9% 384k |
|
| CanSino, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Cambodia |
90.1% 15,068,135 |
85.9% 14,361,140 |
0.1% | 0.1% |
1.8% 297k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Hong Kong |
89.9% 6,740,395 |
85.9% 6,441,948 |
0.1% | 0.3% |
1.5% 113k |
|
| Pfizer/BioNTech, Sinovac | ||||||
| China |
89.9% 1,294,045,000 |
87.6% 1,260,501,000 |
0.0% | 0.0% | ||
| CanSino, IMBCAMS, KCONVAC, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, ZF2001 | ||||||
| Nicaragua |
89.6% 5,938,231 |
83.1% 5,503,047 |
0.3% | 1.0% |
1.3% 88k |
|
| Abdala, Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Soberana02, Sputnik Light, Sputnik V | ||||||
| Peru |
89.4% 29,494,496 |
83.7% 27,591,167 |
0.1% | 0.1% |
1.3% 422k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| New Zealand |
89.0% 4,292,747 |
85.3% 4,114,696 |
0.0% | 0.1% |
0.6% 27k |
|
| Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Taiwan |
88.9% 21,178,300 |
81.6% 19,423,800 |
0.1% | 0.8% |
2.7% 631k |
|
| Medigen, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Vietnam |
88.8% 86,384,303 |
83.3% 81,100,223 |
0.6% | 0.9% |
4.5% 4,403k |
|
| Abdala, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Spain |
88.2% 41,254,310 |
86.7% 40,550,392 |
0.0% | 0.0% |
0.2% 84k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| South Korea |
87.9% 45,068,239 |
87.1% 44,628,221 |
0.0% | 0.0% |
0.2% 80k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Australia |
87.7% 22,351,411 |
85.0% 21,668,833 |
0.0% | 0.1% |
0.2% 59k |
|
| Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Costa Rica |
87.1% 4,437,629 |
81.3% 4,143,017 |
0.2% | 0.2% |
2.4% 123k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Brazil |
86.9% 184,682,893 |
79.5% 168,924,041 |
0.1% | 0.2% |
1.7% 3,578k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Canada |
86.8% 32,777,269 |
83.3% 31,448,069 |
0.0% | 0.0% |
0.2% 83k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Malaysia |
86.6% 28,039,326 |
84.3% 27,276,391 |
0.0% | 0.1% |
0.2% 49k |
|
| CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Uruguay |
86.3% 2,997,331 |
83.1% 2,887,509 |
0.0% | 0.1% |
1.5% 53k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Ecuador |
86.1% 15,182,320 |
79.4% 14,004,436 |
0.0% | 0.1% |
0.8% 143k |
|
| CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Singapore |
85.8% 5,019,556 |
85.4% 4,997,156 |
0.0% | 0.1% |
0.3% 20k |
|
| Moderna, Novavax, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Italy |
84.0% 50,803,153 |
79.3% 47,948,889 |
0.0% | 0.0% |
0.2% 109k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| France |
83.4% 54,457,721 |
81.1% 52,905,213 |
0.0% | 0.0% |
0.7% 437k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Denmark |
83.4% 4,830,444 |
82.8% 4,794,155 |
0.0% | 0.0% |
0.1% 4k |
|
| Johnson&Johnson, Moderna, Pfizer/BioNTech | ||||||
| Colombia |
83.4% 42,418,509 |
71.1% 36,180,137 |
0.1% | 0.1% |
0.6% 307k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Ireland |
82.8% 4,090,474 |
81.9% 4,042,544 |
0.0% | 0.0% |
0.2% 10k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Japan |
82.0% 103,733,788 |
80.9% 102,348,805 |
0.0% | 0.0% |
0.7% 860k |
|
| Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Finland |
81.5% 4,517,181 |
78.2% 4,334,110 |
0.0% | 0.0% |
0.5% 26k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Thailand |
81.2% 56,708,830 |
75.8% 52,891,174 |
0.1% | 0.1% |
0.7% 461k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Panama |
80.7% 3,482,802 |
72.2% 3,114,030 |
0.0% | 0.1% |
0.7% 32k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Kuwait |
80.4% 3,432,854 |
77.8% 3,320,935 |
0.0% | 0.1% |
0.4% 19k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Norway |
80.1% 4,341,776 |
74.7% 4,047,158 |
0.0% | 0.0% |
0.2% 10k |
|
| Moderna, Pfizer/BioNTech | ||||||
| Laos |
80.0% 5,817,695 |
69.8% 5,076,787 |
0.1% | 0.2% |
0.3% 23k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Belgium |
79.8% 9,248,007 |
79.0% 9,150,876 |
0.0% | 0.0% |
0.3% 36k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Sri Lanka |
79.7% 17,073,712 |
67.8% 14,523,208 |
0.0% | 0.0% |
0.1% 10k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| United Kingdom |
78.9% 53,577,314 |
73.8% 50,126,662 |
0.0% | 0.1% |
0.5% 317k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Nepal |
78.9% 22,995,709 |
69.6% 20,267,818 |
1.4% | 0.4% |
2.5% 718k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Bangladesh |
78.5% 129,343,045 |
72.5% 119,422,697 |
0.1% | 0.4% |
1.1% 1,821k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| United States |
78.4% 259,426,758 |
67.1% 222,123,223 |
0.1% | 0.0% |
0.3% 1,084k |
|
| Johnson&Johnson, Moderna, Pfizer/BioNTech | ||||||
| Venezuela |
77.9% 22,157,232 |
50.2% 14,287,370 |
||||
| Abdala, Sinopharm/Beijing, Sinovac, Soberana02, Sputnik Light, Sputnik V | ||||||
| Sweden |
77.6% 7,838,695 |
75.8% 7,651,988 |
0.0% | 0.0% |
0.4% 43k |
|
| Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Israel |
77.6% 6,712,397 |
71.0% 6,145,211 |
0.0% | 0.0% |
0.1% 8k |
|
| Moderna, Pfizer/BioNTech | ||||||
| Germany |
77.2% 64,700,283 |
75.6% 63,347,864 |
0.0% | 0.0% |
0.3% 251k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Mauritius |
76.9% 977,602 |
74.3% 945,000 |
0.0% | 0.0% |
0.1% 2k |
|
| Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Iran |
76.8% 64,545,209 |
68.9% 57,860,379 |
0.0% | 0.1% |
0.2% 161k |
|
| COVIran Barekat, Covaxin, FAKHRAVAC, Oxford/AstraZeneca, Razi Cov Pars, Sinopharm/Beijing, Soberana02, SpikoGen, Sputnik V | ||||||
| Saudi Arabia |
76.7% 26,713,922 |
72.1% 25,082,132 |
0.1% | 0.2% |
1.0% 338k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Greece |
76.0% 7,919,273 |
73.2% 7,629,235 |
0.0% | 0.0% |
0.3% 27k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Austria |
75.8% 6,831,552 |
73.6% 6,625,237 |
0.0% | 0.0% |
0.1% 12k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| India |
73.7% 1,016,506,282 |
66.3% 914,479,703 |
0.1% | 0.4% |
0.7% 9,901k |
|
| Corbevax, Covaxin, Novavax, Oxford/AstraZeneca, Sputnik V | ||||||
| Indonesia |
73.5% 201,000,560 |
61.5% 168,251,795 |
0.1% | 0.1% |
0.7% 1,870k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Bahrain |
72.8% 1,238,378 |
71.9% 1,223,057 |
0.0% | 0.0% |
0.1% 2k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Botswana |
72.1% 1,696,430 |
64.3% 1,512,567 |
0.0% | 0.0% |
0.1% 1k |
|
| Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Lithuania |
71.7% 1,952,388 |
68.9% 1,876,648 |
0.0% | 0.0% |
0.0% 0k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Latvia |
71.4% 1,345,920 |
69.2% 1,305,625 |
0.0% | 0.0% |
0.0% 0k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| El Salvador |
71.2% 4,615,720 |
66.6% 4,319,779 |
0.1% | 0.1% |
0.9% 58k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Switzerland |
70.3% 6,087,852 |
69.4% 6,002,672 |
0.0% | 0.0% |
0.1% 11k |
|
| Johnson&Johnson, Moderna, Pfizer/BioNTech | ||||||
| Rwanda |
70.1% 9,076,533 |
66.1% 8,558,553 |
0.0% | 0.1% |
0.4% 52k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Mongolia |
69.3% 2,272,965 |
66.4% 2,175,617 |
0.0% 1k |
|||
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Philippines |
68.7% 75,286,371 |
64.4% 70,532,636 |
0.4% | 0.3% |
1.1% 1,190k |
|
| Covaxin, Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Turkey |
68.6% 57,858,728 |
63.0% 53,088,281 |
0.0% | 0.0% |
0.0% 18k |
|
| Pfizer/BioNTech, Sinovac, Turkovac | ||||||
| Mexico |
68.5% 88,336,802 |
62.0% 79,947,470 |
0.0% |
0.1% 149k |
||
| CanSino, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V | ||||||
| Belarus |
68.0% 6,425,755 |
66.9% 6,325,490 |
0.1% | 0.3% |
0.5% 50k |
|
| KoviVac/Chumakov, Sinopharm/Beijing, Sputnik Light, Sputnik V | ||||||
| Morocco |
67.6% 24,946,369 |
63.5% 23,429,942 |
0.0% | 0.0% |
0.1% 38k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Dominican Republic |
66.7% 7,236,727 |
55.3% 5,998,771 |
0.0% | 0.0% |
0.2% 26k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Hungary |
66.3% 6,407,918 |
64.1% 6,194,102 |
0.0% | 0.0% |
0.1% 7k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Estonia |
65.1% 863,093 |
63.9% 847,710 |
0.0% | 0.0% |
0.0% 1k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Czechia |
65.0% 6,965,463 |
64.2% 6,879,870 |
0.0% | 0.0% |
0.1% 8k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Oman |
64.0% 3,266,729 |
59.5% 3,039,478 |
0.0% | 0.0% |
0.1% 3k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Honduras |
63.5% 6,293,459 |
54.2% 5,368,598 |
0.1% | 0.1% |
0.3% 35k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V | ||||||
| Timor |
62.4% 822,666 |
52.7% 694,694 |
0.7% | 0.8% |
2.6% 34k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Pakistan |
62.1% 137,108,516 |
57.4% 126,718,132 |
0.3% | 0.6% |
3.2% 7,002k |
|
| CanSino, Covaxin, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Bolivia |
61.9% 7,229,825 |
51.4% 6,003,856 |
0.1% | 0.1% |
0.5% 55k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Tunisia |
61.2% 7,234,385 |
54.0% 6,376,006 |
0.0% | 0.0% |
0.0% 3k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Slovenia |
60.9% 1,265,770 |
58.8% 1,222,170 |
0.0% | 0.0% |
0.0% 0k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Myanmar |
60.7% 33,004,742 |
49.7% 27,027,467 |
1.4% | 0.8% |
2.4% 1,310k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Poland |
60.1% 22,734,782 |
59.5% 22,514,708 |
0.0% | 0.0% |
0.1% 20k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Uzbekistan |
58.6% 19,611,361 |
46.3% 15,485,377 |
0.2% | 0.2% |
2.6% 856k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik Light, Sputnik V, ZF2001 | ||||||
| Croatia |
56.4% 2,315,490 |
54.7% 2,245,155 |
0.0% | 0.0% |
0.0% 1k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Russia |
56.0% 81,792,489 |
51.2% 74,673,362 |
0.2% | 0.2% |
0.5% 694k |
|
| EpiVacCorona, Sputnik V | ||||||
| Paraguay |
55.3% 3,944,590 |
48.4% 3,451,096 |
0.2% | 0.1% |
0.2% 16k |
|
| Covaxin, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Tajikistan |
54.7% 5,220,731 |
52.8% 5,034,819 |
0.1% | 0.1% |
2.7% 256k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V | ||||||
| Trinidad and Tobago |
53.7% 751,247 |
51.0% 714,047 |
0.0% | 0.0% |
0.2% 3k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Azerbaijan |
52.8% 5,353,536 |
47.9% 4,853,215 |
0.0% | 0.0% |
0.1% 9k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V | ||||||
| Slovakia |
51.7% 2,822,399 |
50.7% 2,768,287 |
0.0% |
0.0% 0k |
||
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V | ||||||
| Kazakhstan |
50.0% 9,394,344 |
48.0% 9,010,266 |
0.1% | 0.3% |
0.4% 75k |
|
| QazVac, Sinopharm/Beijing, Sputnik V | ||||||
| Serbia |
49.3% 3,354,075 |
48.2% 3,278,198 |
0.0% | 0.0% |
0.0% 1k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Mozambique |
47.9% 14,978,771 |
45.1% 14,098,645 |
||||
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Egypt |
47.2% 48,283,385 |
34.3% 35,136,269 |
0.4% | 0.4% |
1.2% 1,214k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Jordan |
47.0% 4,795,888 |
44.3% 4,523,642 |
0.0% | 0.1% | ||
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Kosovo |
46.8% 903,637 |
42.6% 823,746 |
0.0% | 0.0% |
0.0% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Guatemala |
46.3% 8,302,756 |
35.4% 6,335,969 |
0.1% | 0.1% |
0.6% 104k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V | ||||||
| Albania |
46.1% 1,325,464 |
43.3% 1,247,475 |
0.1% | 0.1% |
0.3% 8k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V | ||||||
| Lesotho |
43.6% 933,825 |
34.3% 735,610 |
1.4% | 0.1% |
0.3% 6k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Zimbabwe |
42.5% 6,314,124 |
31.1% 4,624,556 |
0.2% | 0.3% |
0.8% 111k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Mauritania |
41.4% 1,925,871 |
28.7% 1,332,967 |
0.0% | 0.0% |
0.1% 2k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| North Macedonia |
41.0% 853,900 |
40.2% 837,400 |
0.1% | 0.0% |
0.2% 3k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, Sputnik V | ||||||
| Georgia |
40.9% 1,631,237 |
31.9% 1,270,848 |
0.0% | 0.0% |
0.1% 2k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac | ||||||
| Lebanon |
39.5% 2,698,736 |
34.8% 2,374,475 |
0.0% | 0.0% |
0.1% 9k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Palestine |
39.4% 2,007,851 |
34.7% 1,771,951 |
0.0% 1k |
|||
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Angola |
38.6% 12,700,926 |
20.7% 6,811,268 |
1.1% | 0.8% |
1.6% 531k |
|
| Oxford/AstraZeneca | ||||||
| Armenia |
38.1% 1,129,669 |
33.3% 985,807 |
0.0% | 0.0% |
0.0% 1k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, Sputnik Light, Sputnik V | ||||||
| South Africa |
37.1% 22,028,992 |
32.1% 19,058,285 |
0.1% | 0.1% |
0.2% 120k |
|
| Johnson&Johnson, Pfizer/BioNTech | ||||||
| Ukraine |
36.1% 15,774,300 |
34.7% 15,153,577 |
0.2% | 0.0% |
0.4% 171k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Uganda |
35.0% 16,032,667 |
24.0% 10,966,811 |
0.2% | 0.2% |
0.2% 111k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Liberia |
34.6% 1,751,520 |
28.4% 1,438,154 |
0.4% 23k |
|||
| Oxford/AstraZeneca | ||||||
| Guinea |
34.5% 4,537,091 |
20.0% 2,623,618 |
0.2% | 0.3% |
0.4% 57k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Ghana |
33.3% 10,352,002 |
22.8% 7,089,576 |
0.6% | 0.7% |
2.4% 748k |
|
| Oxford/AstraZeneca, Sputnik V | ||||||
| Libya |
33.0% 2,269,135 |
17.2% 1,183,940 |
0.1% | 0.0% |
0.2% 13k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Cote d'Ivoire |
30.4% 8,026,397 |
21.0% 5,540,193 |
0.3% | 0.4% | ||
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Sierra Leone |
29.9% 2,383,636 |
20.8% 1,659,093 |
1.2% 97k |
|||
| Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Bosnia and Herzegovina |
28.8% 943,394 |
25.8% 846,080 |
0.3% | 0.3% |
0.9% 30k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V | ||||||
| Romania |
28.5% 5,474,507 |
42.2% 8,114,769 |
0.0% |
0.0% 8k |
||
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| WORLD |
27.5% 2,147,483,647 |
27.5% 2,147,483,647 |
||||
| Jamaica |
27.5% 813,122 |
24.0% 709,895 |
0.1% | 0.1% |
0.1% 3k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Bulgaria |
27.4% 1,904,143 |
29.7% 2,061,806 |
0.0% |
0.1% 5k |
||
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Iraq |
26.9% 10,833,447 |
18.9% 7,609,777 |
0.1% | 0.1% |
0.1% 48k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Guinea-Bissau |
26.9% 529,604 |
17.4% 342,039 |
0.0% | 0.0% |
0.3% 5k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Benin |
26.2% 3,174,135 |
22.2% 2,690,085 |
0.0% | 0.1% |
0.1% 15k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac | ||||||
| Ethiopia |
25.6% 29,380,780 |
22.5% 25,902,313 |
2.0% | 2.0% |
0.3% 303k |
|
| Covaxin, Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac | ||||||
| Togo |
25.3% 2,092,750 |
18.8% 1,557,538 |
0.1% | |||
| Oxford/AstraZeneca | ||||||
| Kyrgyzstan |
24.1% 1,571,358 |
20.2% 1,321,404 |
0.0% | 0.1% |
0.1% 8k |
|
| Sinopharm/Beijing, Sputnik V | ||||||
| Moldova |
23.5% 948,882 |
26.4% 1,063,425 |
0.0% |
0.1% 4k |
||
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Kenya |
23.5% 12,641,679 |
17.4% 9,326,814 |
0.1% | 0.1% |
0.2% 84k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Central African Republic |
23.3% 1,124,848 |
22.1% 1,068,464 |
0.2% | 0.2% |
0.2% 12k |
|
| Covaxin, Oxford/AstraZeneca | ||||||
| Namibia |
19.5% 496,475 |
16.8% 426,681 |
0.2% | 0.2% |
0.0% 1k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Equatorial Guinea |
19.1% 267,610 |
14.8% 208,104 |
0.1% | 0.1% |
0.2% 2k |
|
| Sinopharm/Beijing, Sinovac | ||||||
| Algeria |
18.7% 8,210,605 |
15.6% 6,851,660 |
0.2% | 0.2% | ||
| Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Gambia |
18.6% 449,464 |
14.7% 354,340 |
1.0% 23k |
|||
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Somalia |
16.3% 2,591,679 |
10.1% 1,600,785 |
0.3% 47k |
|||
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Syria |
15.4% 2,694,839 |
10.2% 1,785,107 |
0.1% 13k |
|||
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Afghanistan |
14.5% 5,629,522 |
12.8% 4,979,930 |
0.1% | 0.1% |
0.2% 66k |
|
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Gabon |
13.9% 308,745 |
11.5% 256,226 |
0.0% | 0.0% |
0.0% 0k |
|
| Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Nigeria |
13.8% 28,340,766 |
10.2% 20,986,761 |
0.2% | 1.0% |
1.0% 2,114k |
|
| Oxford/AstraZeneca | ||||||
| Senegal |
13.7% 2,300,648 |
6.3% 1,051,041 |
2.5% | |||
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Zambia |
13.5% 2,487,149 |
24.6% 4,528,604 |
1.1% |
1.5% 282k |
||
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Sudan |
13.5% 5,929,766 |
8.5% 3,742,065 |
0.2% |
0.2% 111k |
||
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Chad |
13.5% 2,218,493 |
12.8% 2,093,522 |
0.0% | 0.0% |
0.0% 1k |
|
| Sinopharm/Beijing | ||||||
| Tanzania |
12.7% 7,588,592 |
6.8% 4,079,863 |
0.5% | 0.1% |
0.4% 217k |
|
| Johnson&Johnson, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Congo |
12.6% 693,902 |
11.8% 652,422 |
0.0% | 1.0% |
0.0% 0k |
|
| Moderna, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V | ||||||
| Burkina Faso |
11.7% 2,449,746 |
7.4% 1,555,077 |
0.0% | 0.0% |
0.0% 4k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Malawi |
10.7% 2,047,317 |
8.3% 1,590,299 |
2.4% | 2.4% | ||
| Johnson&Johnson, Oxford/AstraZeneca | ||||||
| South Sudan |
10.4% 1,164,135 |
10.0% 1,122,087 |
0.7% | 0.7% |
0.7% 77k |
|
| Johnson&Johnson, Oxford/AstraZeneca | ||||||
| Niger |
9.1% 2,198,758 |
6.4% 1,556,817 |
0.0% | 0.0% |
0.0% 5k |
|
| Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Mali |
8.8% 1,781,525 |
6.4% 1,304,066 |
0.2% | 0.1% |
0.2% 49k |
|
| Oxford/AstraZeneca | ||||||
| Cameroon |
5.9% 1,559,801 |
4.6% 1,216,589 |
0.0% | 0.0% |
0.0% 1k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Madagascar |
4.7% 1,290,584 |
4.3% 1,199,011 |
0.2% | |||
| Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Eswatini |
4.5% 387,468 |
3.9% 336,066 |
||||
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Papua New Guinea |
3.8% 337,243 |
3.1% 277,913 |
0.0% | 0.0% |
0.1% 4k |
|
| Oxford/AstraZeneca | ||||||
| Democratic Republic of Congo |
3.3% 2,979,005 |
2.5% 2,272,532 |
0.3% | 0.3% |
0.3% 281k |
|
| Oxford/AstraZeneca | ||||||
| Yemen |
2.3% 697,956 |
1.5% 446,120 |
||||
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||
| Haiti |
2.1% 241,385 |
1.4% 157,276 |
0.2% | 0.1% |
0.2% 23k |
|
| Johnson&Johnson, Moderna | ||||||
| Burundi |
0.1% 14,929 |
0.1% 14,350 |
0.0% | 0.0% |
0.0% 0k |
|
| Johnson&Johnson, Sinopharm/Beijing | ||||||
| PEOPLE VACCINATED | LAST 7 DAYS | |||||
| countries below 1M population |
1st dose |
last dose |
1st dose |
last dose |
any dose |
|
| Gibraltar |
124.9% 42,074 |
122.9% 41,421 |
0.1% |
0.8% 0k |
||
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Samoa |
115.6% 229,291 |
99.9% 198,149 |
0.2% | 2.8% |
3.0% 6k |
|
| Oxford/AstraZeneca | ||||||
| Malta |
108.0% 476,860 |
106.4% 469,780 |
0.0% | 0.0% |
0.8% 3k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Tonga |
102.4% 108,263 |
91.9% 97,151 |
1.0% 1k |
|||
| Oxford/AstraZeneca | ||||||
| Niue |
102.0% 1,650 |
87.6% 1,417 |
1.2% |
6.1% 0k |
||
| Pfizer/BioNTech | ||||||
| Brunei |
101.6% 444,293 |
97.6% 426,764 |
0.3% | 1.2% |
2.4% 10k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Pitcairn |
100.0% 47 |
100.0% 47 |
||||
| Oxford/AstraZeneca | ||||||
| Macao |
94.5% 613,720 |
90.2% 586,020 |
0.2% | 0.1% |
0.6% 4k |
|
| Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Cayman Islands |
93.3% 61,307 |
90.6% 59,547 |
0.1% | 0.2% |
0.6% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Iceland |
90.8% 309,770 |
85.0% 290,193 |
0.0% | 0.0% |
0.1% 0k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Bhutan |
89.8% 692,909 |
87.2% 672,575 |
0.0% | 0.0% |
0.0% 0k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Nauru |
87.3% 9,464 |
79.2% 8,585 |
1.0% | 2.8% |
18.9% 2k |
|
| Oxford/AstraZeneca | ||||||
| Seychelles |
86.4% 84,943 |
82.1% 80,726 |
0.0% | 0.0% | ||
| Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V | ||||||
| Cook Islands |
85.6% 15,033 |
83.6% 14,685 |
0.1% 0k |
|||
| Pfizer/BioNTech | ||||||
| Faeroe Islands |
85.4% 41,715 |
83.7% 40,895 |
0.0% | 0.0% |
0.3% 0k |
|
| Moderna, Pfizer/BioNTech | ||||||
| Aruba |
83.5% 89,179 |
77.6% 82,835 |
0.1% | 0.1% |
0.2% 0k |
|
| Pfizer/BioNTech | ||||||
| Jersey |
82.7% 83,595 |
79.9% 80,755 |
0.0% | 0.1% |
0.5% 0k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Turks and Caicos Islands |
82.6% 31,989 |
77.4% 29,963 |
0.2% | 0.1% |
0.3% 0k |
|
| Pfizer/BioNTech | ||||||
| Isle of Man |
81.8% 69,560 |
78.9% 67,106 |
0.0% 0k |
|||
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Guernsey |
80.8% 54,146 |
76.6% 51,351 |
0.4% 0k |
|||
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Fiji |
78.8% 706,496 |
70.8% 635,168 |
0.0% | 0.0% |
0.1% 0k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Bermuda |
78.0% 48,554 |
76.5% 47,657 |
0.1% |
0.1% 0k |
||
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| San Marino |
77.7% 26,357 |
69.6% 23,633 |
0.1% 0k |
|||
| Pfizer/BioNTech, Sputnik V | ||||||
| Luxembourg |
76.9% 481,281 |
6.1% 37,870 |
0.0% |
0.2% 1k |
||
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Cyprus |
76.3% 668,493 |
73.7% 645,099 |
0.0% | 0.0% |
0.1% 1k |
|
| Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Falkland Islands |
75.6% 2,632 |
51.0% 1,775 |
0.8% | 1.7% |
2.4% 0k |
|
| Oxford/AstraZeneca | ||||||
| Andorra |
74.9% 57,883 |
69.2% 53,453 |
0.1% 0k |
|||
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Maldives |
73.8% 398,751 |
71.1% 384,347 |
0.0% | 0.0% |
0.1% 0k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V | ||||||
| Monaco |
73.6% 28,875 |
65.4% 25,667 |
0.4% | 0.4% |
2.8% 1k |
|
| Pfizer/BioNTech | ||||||
| Bonaire Sint Eustatius and Saba |
72.9% 19,109 |
63.8% 16,736 |
2.5% | 2.8% |
5.2% 1k |
|
| Moderna, Pfizer/BioNTech | ||||||
| Greenland |
72.7% 41,243 |
67.8% 38,502 |
0.0% 0k |
|||
| Moderna | ||||||
| Anguilla |
72.1% 10,813 |
67.9% 10,183 |
0.1% | 0.4% |
0.9% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Liechtenstein |
70.1% 26,744 |
69.3% 26,429 |
0.1% 0k |
|||
| Johnson&Johnson, Moderna, Pfizer/BioNTech | ||||||
| Kiribati |
67.4% 80,566 |
50.8% 60,670 |
0.2% | 0.7% |
0.9% 1k |
|
| Oxford/AstraZeneca | ||||||
| French Polynesia |
67.1% 188,352 |
64.4% 180,807 |
0.3% |
0.3% 1k |
||
| Johnson&Johnson, Pfizer/BioNTech | ||||||
| Sint Maarten (Dutch part) |
66.1% 28,357 |
61.5% 26,350 |
0.1% | 0.0% |
0.2% 0k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| New Caledonia |
66.0% 188,411 |
63.2% 180,351 |
0.0% | 0.0% |
0.1% 0k |
|
| Pfizer/BioNTech | ||||||
| Curacao |
66.0% 108,280 |
60.7% 99,589 |
0.0% | 0.0% |
0.1% 0k |
|
| Moderna, Pfizer/BioNTech | ||||||
| Antigua and Barbuda |
65.4% 64,091 |
63.3% 62,031 |
0.0% | 0.1% |
0.1% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V | ||||||
| British Virgin Islands |
64.1% 19,389 |
59.8% 18,083 |
0.1% | 0.1% |
0.2% 0k |
|
| Johnson&Johnson, Oxford/AstraZeneca | ||||||
| Cape Verde |
63.9% 355,377 |
55.3% 307,526 |
0.0% | 0.0% |
0.5% 3k |
|
| Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Belize |
62.4% 247,975 |
53.6% 213,197 |
0.4% | 0.2% |
0.6% 2k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Guyana |
61.3% 481,810 |
58.5% 460,005 |
0.4% | 10.2% |
10.7% 84k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Saint Kitts and Nevis |
58.6% 31,162 |
49.4% 26,294 |
0.1% | 0.1% |
0.2% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Wallis and Futuna |
57.7% 6,483 |
57.4% 6,457 |
0.4% 0k |
|||
| Moderna | ||||||
| Barbados |
56.6% 162,616 |
53.4% 153,510 |
0.0% | 0.1% |
0.1% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Sao Tome and Principe |
56.2% 123,088 |
41.9% 91,836 |
4.1% | 2.1% |
2.7% 6k |
|
| Oxford/AstraZeneca | ||||||
| Vanuatu |
56.1% 172,232 |
41.2% 126,591 |
0.3% |
0.3% 1k |
||
| Oxford/AstraZeneca | ||||||
| Montenegro |
46.4% 291,544 |
45.2% 283,697 |
0.0% | 0.0% |
0.0% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V | ||||||
| Dominica |
45.7% 32,872 |
42.3% 30,474 |
0.0% | 0.0% |
0.0% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Suriname |
45.7% 267,820 |
40.5% 237,879 |
0.0% | 0.0% |
0.0% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing | ||||||
| Bahamas |
42.3% 166,471 |
40.2% 157,964 |
0.1% | 0.1% |
0.3% 1k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Solomon Islands |
41.2% 283,298 |
25.9% 177,996 |
0.8% |
0.8% 5k |
||
| Oxford/AstraZeneca | ||||||
| Montserrat |
40.9% 2,044 |
37.4% 1,868 |
0.4% |
0.5% 0k |
||
| Oxford/AstraZeneca | ||||||
| Comoros |
39.2% 341,302 |
34.6% 301,218 |
0.0% 0k |
|||
| Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing | ||||||
| Grenada |
38.9% 43,745 |
34.3% 38,549 |
0.0% | 0.0% |
0.0% 0k |
|
| Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Saint Vincent and the Grenadines |
33.1% 36,742 |
27.8% 30,855 |
0.1% | 0.1% |
0.2% 0k |
|
| Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik Light, Sputnik V | ||||||
| Saint Lucia |
32.5% 59,583 |
29.6% 54,283 |
0.0% | 0.1% |
0.1% 0k |
|
| Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech | ||||||
| Djibouti |
19.1% 188,889 |
15.1% 148,843 |
0.0% 0k |
|||
| CanSino, Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V | ||||||